• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌的免疫微环境。

The immune microenvironment of cancer of the uterine cervix.

机构信息

First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Department of Pathology, Faculty of Medicine, University of Ioannina, Ioannina, Greece.

出版信息

Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1.

DOI:10.14670/HH-18-727
PMID:38483012
Abstract

While several treatment choices exist for cervical cancer, such as surgical therapy, chemotherapy, and radiotherapy, some patients will still show poor prognosis. HPV infection is a principal factor for cervical cancer development, from early inflammation to proliferation, angiogenesis, and neoplastic growth. While HPV T-cell responses exist, the tumor seems to evade the immune system upon its tolerance. The latter suggests the existence of a confluent tumor microenvironment responsible for the evasion tactics employed by the neoplasm. Therefore, novel biomarkers governing prognosis and treatment planning must be developed, with several studies tackling the significance of the tumor microenvironment in the genesis, development, proliferation, and overall response of cervical cancer during neoplastic processes. This review aims to analyze and contemplate the characteristics of the tumor microenvironment and its role in prognosis, progression, evasion, and invasion, including therapeutic outcome and overall survival.

摘要

虽然宫颈癌有几种治疗选择,如手术治疗、化疗和放疗,但仍有部分患者预后不佳。HPV 感染是宫颈癌发展的一个主要因素,从早期炎症到增殖、血管生成和肿瘤生长。尽管存在 HPV T 细胞反应,但肿瘤似乎在耐受时逃避了免疫系统。后者表明存在一个融合的肿瘤微环境,负责肿瘤所采用的逃避策略。因此,必须开发新的生物标志物来预测预后和治疗计划,许多研究都在探讨肿瘤微环境在肿瘤发生、发展、增殖以及肿瘤过程中宫颈癌整体反应中的意义。本综述旨在分析和思考肿瘤微环境的特征及其在预后、进展、逃避和侵袭中的作用,包括治疗结果和总生存率。

相似文献

1
The immune microenvironment of cancer of the uterine cervix.宫颈癌的免疫微环境。
Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1.
2
[Research progress of tumor-associated macrophages in cervical cancer].[宫颈癌中肿瘤相关巨噬细胞的研究进展]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024 May;40(5):472-478.
3
Understanding HLA-G driven journey from HPV infection to cancer cervix: Adding missing pieces to the jigsaw puzzle.了解 HLA-G 驱动的 HPV 感染到宫颈癌的历程:为拼图游戏添加缺失的部分。
J Reprod Immunol. 2020 Nov;142:103205. doi: 10.1016/j.jri.2020.103205. Epub 2020 Oct 21.
4
Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.人乳头瘤病毒高病毒载量诱导的局部免疫抑制:宫颈肿瘤病变中产生白细胞介素-10的细胞表型特征
Immunology. 2015 Sep;146(1):113-21. doi: 10.1111/imm.12487. Epub 2015 Jul 1.
5
HPV post-infection microenvironment and cervical cancer.HPV 感染后微环境与宫颈癌。
Cancer Lett. 2021 Jan 28;497:243-254. doi: 10.1016/j.canlet.2020.10.034. Epub 2020 Oct 27.
6
Induction of systemic immune responses and reversion of immunosuppression in the tumor microenvironment by a therapeutic vaccine for cervical cancer.治疗性宫颈癌疫苗诱导全身性免疫反应并逆转肿瘤微环境中的免疫抑制。
Cancer Immunol Immunother. 2020 Dec;69(12):2651-2664. doi: 10.1007/s00262-020-02651-3. Epub 2020 Jul 1.
7
Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer.GLUT1 过表达对人乳头瘤病毒 16 阳性和阴性宫颈癌患者生存和肿瘤免疫微环境的差异影响。
Sci Rep. 2019 Sep 16;9(1):13301. doi: 10.1038/s41598-019-49928-x.
8
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.人乳头瘤病毒相关性癌症的免疫发病机制与免疫治疗前景。
Viruses. 2017 Sep 12;9(9):254. doi: 10.3390/v9090254.
9
Increased High-Risk Human Papillomavirus Viral Load Is Associated With Immunosuppressed Microenvironment and Predicts a Worse Long-Term Survival in Cervical Cancer Patients.高危型人乳头瘤病毒病毒载量增加与免疫抑制微环境相关,并预测宫颈癌患者的长期生存预后更差。
Am J Clin Pathol. 2020 Mar 9;153(4):502-512. doi: 10.1093/ajcp/aqz186.
10
Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.人乳头瘤病毒及相关抗原在人宫颈肿瘤局部癌环境中的免疫概念
J Obstet Gynaecol Res. 2007 Apr;33(2):103-13. doi: 10.1111/j.1447-0756.2007.00492.x.

引用本文的文献

1
Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer.NTRK融合基因在人乳头瘤病毒(±)宫颈癌肿瘤免疫微环境中的作用
J Med Virol. 2025 Aug;97(8):e70564. doi: 10.1002/jmv.70564.
2
Clonal Hematopoiesis of Intermediate Potential in Atrial Fibrillation: A Critical View of Current Knowledge as a Springboard for Future Research.心房颤动中具有中等潜能的克隆性造血:对当前知识的批判性审视作为未来研究的跳板
Diagnostics (Basel). 2025 Jul 30;15(15):1915. doi: 10.3390/diagnostics15151915.
3
T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.

本文引用的文献

1
Human papillomavirus vaccination and cervical cancer risk.人乳头瘤病毒疫苗接种与宫颈癌风险。
BMJ. 2022 Dec 15;379:e070115. doi: 10.1136/bmj-2022-070115.
2
Stromal or intraepithelial tumor-infiltrating lymphocytes: which one has more prognostic significance in cervical cancer?间质或上皮内肿瘤浸润淋巴细胞:哪一种在宫颈癌中具有更重要的预后意义?
Arch Gynecol Obstet. 2023 Mar;307(3):969-980. doi: 10.1007/s00404-022-06687-x. Epub 2022 Jul 16.
3
Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer.
宫颈癌肿瘤微环境中的T细胞亚群:进展与治疗机遇
Front Immunol. 2025 Jun 5;16:1612032. doi: 10.3389/fimmu.2025.1612032. eCollection 2025.
4
Diagnostic and Therapeutic Implications of the SUMOylation Pathway in Acute Myeloid Leukemia.SUMO化途径在急性髓系白血病中的诊断和治疗意义
Cancers (Basel). 2025 Feb 13;17(4):631. doi: 10.3390/cancers17040631.
5
Hepatic Iron Overload and Hepatocellular Carcinoma: New Insights into Pathophysiological Mechanisms and Therapeutic Approaches.肝铁过载与肝细胞癌:病理生理机制及治疗方法的新见解
Cancers (Basel). 2025 Jan 24;17(3):392. doi: 10.3390/cancers17030392.
6
An exploration of the natural and acquired immunological mechanisms to high-risk human papillomavirus infection and unmasking immune escape in cervical cancer: A concise synopsis.高危型人乳头瘤病毒感染的天然和获得性免疫机制及宫颈癌免疫逃逸揭秘探索:简要概述
Tzu Chi Med J. 2024 Dec 3;37(1):28-41. doi: 10.4103/tcmj.tcmj_134_24. eCollection 2025 Jan-Mar.
髓源性抑制细胞通过 BAFF/BAFF-R 通路与 B10 细胞相互作用,促进宫颈癌的免疫抑制。
Cancer Immunol Immunother. 2023 Jan;72(1):73-85. doi: 10.1007/s00262-022-03226-0. Epub 2022 Jun 20.
4
Updates on systemic therapy for cervical cancer.宫颈癌系统治疗进展。
Indian J Med Res. 2021 Aug;154(2):293-302. doi: 10.4103/ijmr.IJMR_4454_20.
5
The percentage of peripheral eosinophils as a sensitive marker for differentiating FIGO grade in endometrial adenocarcinomas.外周血嗜酸性粒细胞百分比作为子宫内膜腺癌国际妇产科联盟(FIGO)分级鉴别敏感标志物的研究
J Turk Ger Gynecol Assoc. 2022 Jun 1;23(2):99-105. doi: 10.4274/jtgga.galenos.2022.2021-9-10. Epub 2022 Mar 10.
6
PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer.CD8 +肿瘤浸润淋巴细胞上的PD-1表达状态与宫颈癌患者的生存率相关。
Front Oncol. 2021 Jun 4;11:678758. doi: 10.3389/fonc.2021.678758. eCollection 2021.
7
The correlation between tumor-associated macrophage infiltration and progression in cervical carcinoma.肿瘤相关巨噬细胞浸润与宫颈癌进展的相关性。
Biosci Rep. 2021 May 28;41(5). doi: 10.1042/BSR20203145.
8
Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.肿瘤微环境特征分析在宫颈癌中确定了具有预后相关性的基因特征。
PLoS One. 2021 Apr 26;16(4):e0249374. doi: 10.1371/journal.pone.0249374. eCollection 2021.
9
Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer: The Role of Immune-related Factors.局部晚期宫颈癌新辅助化疗的反应:免疫相关因素的作用。
In Vivo. 2021 Mar-Apr;35(2):1277-1283. doi: 10.21873/invivo.12379.
10
Immune checkpoint expression on peripheral cytotoxic lymphocytes in cervical cancer patients: moving beyond the PD-1/PD-L1 axis.宫颈癌患者外周细胞毒性淋巴细胞上的免疫检查点表达:超越 PD-1/PD-L1 轴。
Clin Exp Immunol. 2021 Apr;204(1):78-95. doi: 10.1111/cei.13561. Epub 2021 Jan 18.